A DONE BY: RONO KIPROTICH VICTOR U29/28970/2009 A COMPARATIVE STUDY ON DISSOLUTION PROFILES OF AMOXICILLIN IN AMOXICILLIN CONTAINING CAPSULES AVAILABLE.

Slides:



Advertisements
Similar presentations
6 th Annual Science and Standards Symposium January 16, 2013 Istanbul Determination of Solubility and Permeability in BCS Erika Stippler, Ph.D. Director.
Advertisements

Analysis of B Vitamins Analysis of B Vitamins in Various Energy Drinks Chez Brivett Dr. William Nirode Hofstra University.
COUNTERFEITING OF DRUGS AND THE NECESSITY OF QC SYSTEMS IN DEVELOPING COUNTRIES: THE KENYAN EXPERIENCE By Isaac O. Kibwage.
By Timina Olive Kayaviri Supervisor : Dr. Amugune
Quality Control of Medicines and Organization of Market Surveillance in Kenya Dr. H. K. Chepkwony, PhD Director, National Quality Control Laboratory (NQCL);
BY: PATEL MINAL NARAN U29/35243/2010 SUPERVISOR: DR. P. M. NJOGU
Introduction: Hydrogels are three dimensional cross linked polymers. They are highly desired because of their flexibility, hydrophilic nature, and because.
HPLC ANALYSIS OF AZITHROMYCIN SUSPENSIONS AND TABLETS
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Introduction to the Discussion of Bioequivalence.
POST MARKET SURVEILLANCE OF MEFENAMIC ACID CAPSULES AND TABLETS RETAILING IN NAIROBI, KENYA Research by : Khushali Naran Pindoria U29/35778/2010 Supervisor:
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
A COMPARATIVE STUDY ON THE IN VITRO DISSOLUTION PROFILES OF COMMERCIALLY AVAILABLE CLARITHROMYCIN ORAL DOSAGE FORMS IN NAIROBI COUNTY, KENYA By: Manani.
STRUCTURE AND PROCESS OF PERIODIC SAFETY UPDATE REPORTING SYSTEM MEDICINES IN KENYA KIOGORA MWITI GATIMBU REG NO.U51/64042/2013 M.PHARM-EPIVIGIL 24 TH.
Dale P. Conner, Pharm.D. Division of Bioequivalence OGD, CDER, FDA
Bioavailability and Bioequivalence
1 Advisory Committee for Pharmaceutical Science May 3, 2005 Factors Impacting Drug Dissolution and Absorption : Current State of Science Lawrence X. Yu,
Hanoi, WORKSHOP ON PREQUALIFICATION OF ARV: BIOEQUIVALENCE Introduction to the Discussion of Bioequivalence Study Design and Conduct Presented.
World Health Organization
Artemisinin combined medicines, Kampala, February |1 | Training workshop on regulatory requirements for registration of Artemisinin based combined.
Tanzania, August, 2006 Dr. Barbara Sterzik, BfArM, Bonn 1 Guidelines and Tools available TRS 937 and BTIF (Bioequivalence Trial Information Form)
WELCOME. UV Spectrophotometric Method Development And Estimation of Bicalutamide in Pharmaceutical Dosage Form.
Bioequivalence Studies Dr Sanet Aspinall, PhD Managing Director AddClin Research Pretoria 20 March 2009.
Establishing Drug release/Dissolution Specifications – QBD Approach Moheb M. Nasr, Ph.D. Office of New Drug Quality Assessment (ONDQA), OPS, CDER Advisory.
Week 6- Bioavailability and Bioequivalence
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
COMPARATIVE IN VITRO EVALUATION OF GENERIC CIPROFLOXACIN HYDROCHLORIDE TABLETS IN KENYA BY DANIEL MINYETO U59/81286/2012 Department of Pharmaceutical Chemistry.
QUALITY OF CARBAMAZEPINE TABLETS IN NAIROBI COUNTY BY: KAINGU WINNIE MSINDA U29/2014/2010 SUPERVISOR: DR. K.O. ABUGA OCTOBER 2014.
WHO Workshop on Assessment of Bioequivalence Data BCS-Biowaivers - Template Dr. Henrike Potthast WHO Workshop on Assessment of.
Siobhan Dougherty 9 th Grade. Problem The problem in this experiment is to see whether generic or brand name pain relievers will dissolve faster. Is it.
Medicines Transparency Alliance24/10/ Addressing Quality in MeTA - Ghana Daniel Kojo Arhinful PhD Senior Technical Advisor MeTA Ghana.
<701> DISINTEGRATION
WHO Workshop on Assessment of Bioequivalence Data Addis Ababa, 31. August – 3. September 2010 Artemisinin-based Products Dr. Henrike Potthast
Assessment of Interchangeable Multisource Medicines BCS-Biowaivers - Template Dr. Henrike Potthast Training workshop: Assessment of.
Factors Affecting Stability of Quinidine Melissa Usry and Sharmistha Basu-Dutt Department of Chemistry, University of West Georgia, Carrollton, GA
The USP Performance Test Dissolution Systems Suitability Studies Walter W. Hauck, Ph.D. USP Consultant Presentation to Advisory Committee for Pharmaceutical.
1 Abu Alam Ph.D. Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 23, 2008.
Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview
WHO Prequalification Programme June 2007 Training Workshop on Dissolution, Pharmaceutical Product Interchangeability and Biopharmaceutical Classification.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
The Biopharmaceutical Classification System (BCS)
Introduction What is a Biowaiver?
Bioavailability and Bioequivalence L 10,11.  Bioavailability is a measurement of the rate and extent (amount) to which the active ingredient or active.
Pharmacology Basics Presentation Name Course Name
Interchangeability and study design Drs. Jan Welink Training workshop: Assessment of Interchangeable Multisource Medicines, Kenya, August 2009.
Quality Assurance of Medicines under Universal Health Coverage Program by Siriwat Tiptaradol (Presenter) Duangporn Abhigantaphand Sooksri Ungboriboonpisal.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.
Effect of Δ-9-Tetrahydrocannabinol on the Growth of Common Gut Bacteria Δ-9-Tetrahydrocannabinol, or THC, is the most well-known compound in a group of.
In vitro - In vivo Correlation
The First Conference for Medicines Regulatory Authorities In Sudan and Neighboring Countries Khartoum December 2014 Alain PRAT, Technical Officer,
Evaluation of quality and interchangeability of medicinal products - EAC/EC/WHO Training workshop / September |1 | Prequalification programme:
Definitions and Concepts
Dissolution Test (U.S.P.): Two set of apparatus: Apparatus-1: A single tablet is placed in a small wire mesh basket attached to the bottom of the shaft.
Ensuring quality of medicines procured with Global Fund resources HIV AIDS conference Satellite on Essential Medicines for HIV AIDS Mexico 6 August 2008.
Inclusion Complexes of Piroxicam with B-Cyclodextrin Derivatives
Purchase Amoxicillin Online
The Biopharmaceutical Classification System (BCS)
Introduction What is a Biowaiver?
EVALUATION OF HEMOCHROMA POC Hb READER
HPLC ANALYSIS OF AZITHROMYCIN SUSPENSIONS AND TABLETS
Biopharmaceutics of modified release drug products
Dissolution testing and in vitro in vivo correlation of conventional and SR preparations Formulation development and optimization is an ongoing process.
Quality control Lecture 1.
J.Preethi*, P. Madhu, K. Arshad Ahmed Khan.
Biopharmaceutics and pharmacokinetics
Selected Bioavailability and Pharmacokinetic Calculations
Biopharmaceuitcs lab 6 In vitro dissolution study of per – oral tablet.
Quality control Lecture 1.
Evaluation of tablet dosage form 5) dissolution
RingCap Technology Mrs. Maria Saifee Associate Professor,
Presentation transcript:

A DONE BY: RONO KIPROTICH VICTOR U29/28970/2009 A COMPARATIVE STUDY ON DISSOLUTION PROFILES OF AMOXICILLIN IN AMOXICILLIN CONTAINING CAPSULES AVAILABLE IN THE KENYAN MARKET. DONE BY: RONO KIPROTICH VICTOR U29/28970/ /14/2015

INTRODUCTION Drugs have always been subjected to periodic tests on quality and Dissolution is one of the methods used, it is a measure of bioequivalence in vitro which can as well be used to predict bioequivalence in the body Belongs to a subgroup of β-lactam antibiotics called Penicillins which is used regularly to treat gram positive infections e.g. respiratory tract infections,it is available in different dosage forms

JUSTIFICATION To achieve therapeutic response, the solid pharmaceutical form has to disintegrate into active substance dissolved and absorbed into systemic circulation This therefore means that dissolution is the rate limiting step of absorption of an active substance This study allows the probe of capsule invivo/invitro correlation since one can argue that fast dissolution of a capsule or a tablet leads to good bioavailability of the drug in the circulating system

OBJECTIVES The main objectives of this study was to carry out a comparative dissolution profiles of amoxicillin capsules available in the Kenya market and compare with the original brand.

METHODOLOGY The dissolution of the five samples were done in accordance with the 2009 U.S.P requirements Dissolution machine fitted with basket was used,100RPM, for 60 minutes The amoxicillin standard was obtained from DARU laboratories 900ml of distilled water was used as a medium at 37 o Celsius UV-VIS Spectrophotometer from NQCL as an analytical technique

SAMPLES Samples were purchased randomly from dispensing chemist in Nairobi (All 500mg) as follows 2 locally manufactured amoxicillin capsules brands 2 imported brands Amoxil ™ from GSK as the innovator

RESULTS The data collected on the absorbance of different amoxicillin brands selected plus that of the standard at a constant wavelength of 272nm in accordance with U.S.P 2009 were tabulated as indicated in the project,for example

DISCUSSION On calculation of the percentage content of each brand,all the five tested products can be compared as follows 1.Amoxil (106%) 2.Amoximed (103%) 3.Penamox(101%) 4.Zeemox(100%) 5.Kemoxyl (93%)

CONCLUSION Most generic brands of amoxicillin capsules available in the Kenyan market are interchangeable with the innovator brand (Amoxil™), this study supports the argument since all of the five products tested show no significant difference in dissolution

RECOMMENDATIONS Overall, it can be recommended that drug regulatory Authorities should be reinforced and capacitated in order to address proper post marketing surveillance for sensitive medicines like antibiotics. Further studies should be done on the tested products for better conclusion of the interchangeability with the innovator.

ACKNOWLEDGEMENT  I wish to personally acknowledge the help and assistance accorded to me by: 1. Dr J.O.Ogeto, my supervisor from the Department of Pharmaceutical chemistry 2. The technical staff in the department of pharmaceutical chemistry especially Mr.Mugo 3. The National Quality Control Laboratory for their approval of my request to use their UV machine.

THANK YOU ALL FOR LISTENING